The unique poly(U/UC) tract, the middle part of the tripartite 3h non-coding region (3hNCR) of hepatitis C virus (HCV) genomic RNA, may represent a recognition signal for the HCV replicase complex. In this study, several proteins binding specifically to immobilized ribooligonucleotide r(U) 25 mimicking this structure were identified using cytosolic extracts from HCV-negative or -positive liver explants, and a prominent 36 kDa protein was studied further. Competition experiments including homoribopolymers revealed binding affinities in the order : oligo/poly(U) S (A) S (C) S (G). The protein was identified as glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a multifunctional protein known to bind RNA. GAPDH bound efficiently to the full-length HCV RNA and binding to various 3hNCR constructs revealed critical dependence upon the presence of the middle part of the 3hNCR. Polypyrimidine tract-binding protein, described previously to bind the 3hNCR, did not bind efficiently to the middle part of 3hNCR and was captured from liver extracts in considerably smaller quantities.
and helicase activities ; NS4b and NS5a, components of the replicase complex ; and NS5b, the RNA-dependent RNA polymerase) (Clarke, 1997 ; Major & Feinstone, 1997) . The tripartite 3h non-coding region (3hNCR) of HCV RNA (Tanaka et al., 1995 ; Kolykhalov et al., 1996) is unique among viruses, containing a variable length poly(U\UC) tract. It is a candidate for sequence\structural recognition and\or assembly signal for components of the replicase complex, which is usually located in the 3hNCR of positive-strand genomic RNA viruses and interacts with viral and cellular proteins constituting the complex (Kusov et al., 1996 ; Yu & Leibowitz, 1995 ; Todd et al., 1995) .
Several cellular proteins interacting with HCV RNA 3hNCR were identified in extracts of uninfected or untransfected cell lines using UV-cross-linking or gel-retardation techniques and one has been characterized repeatedly as polypyrimidine tractbinding protein (PTB) (Tsuchihara et al., 1997 ; Ito & Lai, 1997 , 1999 Chung & Kaplan, 1999) . We used an alternative RNA capture system (Petrik et al., 1997) , with immobilized ribooligonucleotides or in vitro RNA transcripts corresponding to various combinations of the 3hNCR components and modified to bind proteins from HCV-infected or control cytosolic liver explant extracts.
Liver tissue (D. G. D. Wight), stored at k70 mC, prepared with ice-cold homogenization buffer (0n3 M sucrose, 4 mM CaCl # , 1 mM PMSF) and a Dounce homogenizer, was centrifuged at 300 g (pellet discarded), 1600 g (nuclear pellet) and 10 000 g resulting in a cytosolic extract (supernatant). Total protein concentration was measured and aliquots containing usually 25 µg of total protein were used for capture.
Initial experiments targeted the middle part of tripartite 3hNCR [poly(U\UC) tract] mimicked by a 5h biotinylated ribooligonucleotide r(U) #& [synthesized with its counterpart r(A) #& in the MRC, LMB, Cambridge, UK] immobilized on streptavidine-coated paramagnetic particles (S-PMP ; Promega). After washing and r(U) #& -binding, the S-PMP were resuspended in 2i TTGED (20 mM Tris-HCl pH 8n0, 0n01 % Triton X-100, 10 % glycerol, 1 mM EDTA, 1 mM DTT, 1 mM PMSF) containing 100 mM NaCl unless specified otherwise. An equal volume of the cytoplasmic extract diluted with homogenization buffer was added. After 30 min incubation at 0001-6354 # 1999 SGM 4 mC with gentle mixing and two 5 min washing steps with 1i TTGED-50 mM NaCl, bound proteins were eluted with SDS-PAGE loading buffer (Novex), by heating for 10 min at 70 mC and analysed on Bis-Tris NuPage gels (Novex ; 10 %) with Mes running buffer. Eluted proteins were detected by silver staining. Fig. 1 shows r(U) #& -captured proteins from cytosolic extracts of two controls and three HCV-positive liver explants. There were at least six proteins binding to r(U) #& specifically compared to background captured on S-PMP without ligand. All the proteins were cellular since they were also present in control samples.
The prominent r(U) #& -binding 36 kDa protein was studied in more detail. In order to determine its binding specificity, protein capture was undertaken using biotinylated r(U) #& and its complement, r(A) #& , immobilized on S-PMP, using cytosolic extract from a representative sample (Fig. 2) . The 36 kDa protein bound r(A) #& less efficiently than r(U) #& . In competition experiments in which cytosolic extract was preincubated for 15 min at 4 mC with 50-fold excess of ribohomopolymers [poly(A), (C), (G), (U) ; NCI] prior to capture, poly(U) and poly(A) abrogated the 36 kDa protein capture almost completely, the effect of poly(C) was partial and that of poly(G) minimal. Comparison of the amount of the 36 kDa protein binding to equimolar quantities of r(U) #& and r(A) #& respectively revealed a higher affinity of this protein for r(U) #& . We concluded that the homooligomer\polymer binding affinities of the 36 kDa protein were oligo\poly(U) (A) (C) (G).
To identify the 36 kDa protein, N-terminal sequencing (Nucleic Acid and Protein Synthesis Facility, Department of Biochemistry, University of Cambridge, UK) was carried out. A complete match of the first 19 residues identified the protein as human hepatic glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (Petrik et al., 1998) , a multifunctional cellular protein occurring in several molecular forms and numerous isoforms with varied function (Glaser & Gross, 1995 ; Saunders et al., 1999) . GAPDH, a key enzyme of glycolysis, interacts with other proteins, including actin (Mejean et al., 1989) and tubulin (Huitorel & Pantaloni, 1985) , as well as RNA, including viral RNAs (Singh & Green, 1993 ; Nagy & Rigby, 1995 ; De et al., 1996) , and exhibits RNA helix-destabilizing activity (Karpel & Burchard, 1981 ; Schultz et al., 1996) .
To determine GAPDH binding specificity we prepared plasmid constructs containing various combinations of 3hNCR parts. Fragments corresponding to HCV 3hNCR region 1 (3hNCR1), a consensus sequence of the 40 nucleotide region following the stop codon, from several isolates (Yamada et al., 1996) and the 101 nucleotide conserved region (3hNCR3) were cloned after annealing synthetic oligonucleotides containing extra sequences, complementary to the overhangs of HindIII\ EcoRI-digested TOPO 2.1 plasmid. For the amplification of the remaining five regions of 3hNCR we used DNA of plasmid p90\HCVFL long pU (p90) containing a full-length HCV cDNA clone (Kolykhalov et al., 1997 ; provided by C. Rice). PCR products were subsequently cloned into a PCR 2.1 TOPO vector (Invitrogen). Primers used : for amplification of complete 3hNCR1j2j3 containing a short extra NS5b sequence, primers C3S2 (TGTGCGTCGTGCCGCGACCGCACG) and 4158, corresponding to the 3h end of the conserved 3hNCR3 region (ACATGATCTGCAGAGAGGCC) ; for amplification of complete 3hNCR1j2j3, primers 2546 (AGGTTGGGGTAAACACTCCG) and 4158 ; for amplification of 3hNCR1j2, primers 2546 and 2548 (CACCATTAAAGAAGGAAGGA) ; for amplification of 3hNCR2j3, primers 2547 (GCCATTTCCTGTTTTTTTTT) and 4158 ; for amplification of 3hNCR2, primers 2547 and 2548. As a control we used plasmid containing a 120 nucleotide sequence of 18S RNA. For in vitro transcription plasmid p90 was digested with MluI and all other plasmids with HindIII. Transcription used the T7 and T3 Ampliscribe kit (Epicentre), including or omitting biotin-UTP (Boehringer Mannheim, 1\20 of the concentration of other NTPs) in the ribonucleotide mix. Biotinylated RNA transcripts (0n7 pmol unless stated otherwise) were used for protein capture and non-biotinylated transcripts for competition experiments. For protein capture, in addition to TTGED-50 mM NaCl buffer, we also used HTGEM (10 mM HEPES pH 7n9, 0n1 mM EDTA, 0n01 % Triton X-100, 10 % glycerol, 2 mM MgCl # ) containing 25 mM KCl, similar to buffers used for gel-retardation or UV-crosslinking studies (Furuya & Lai, 1993 ; Kusov et al., 1996 ; Schultz et al., 1996 ; Ito & Lai, 1997) . GAPDH capture with both buffer systems was similar.
Apart from binding to r(U) #& (Fig. 3 a, lane 4) , GAPDH bound strongly to all capture probes containing 3hNCR2 (lanes 3, 6-9), but not to 3hNCR1 or 3hNCR3 or control rRNA (Fig.  3 a, lanes 2, 5, 11 ). GAPDH also bound strongly to the fulllength HCV RNA transcript. The binding was specific, with inhibition of capture on the complete 3hNCR1j2j3 probe specifically by a 10-fold excess of non-biotinylated 3hNCR transcripts containing 3hNCR2 (lanes 3, 6-9 in Fig. 3 d) . Binding was also inhibited by r(U) #& oligo ( Fig. 3 d, lane 4) and by full-length HCV RNA (Fig. 3 d, lane 10) . Amounts of S-PMP, capture probe and cytosolic extract were reduced in this experiment by a factor of five in order to include a 10-fold excess of some competing probes. Correspondingly, the GAPDH bands in Fig. 3 (d) are weaker than in Fig. 3 (c) . Immunodetection after protein transfer onto a PVDF membrane (Immobilon P ; Millipore) using a Novex gel\transfer system and incubation with anti-GAPDH monoclonal antibody (Chemicon) and anti-mouse IgG-HRP conjugate (Sigma) confirmed the identity of captured GAPDH. After washing the membrane was developed using the ECL system (Amersham) and exposed to X-ray film (Fig. 3 c) . Only oligo\poly(U)-containing capture probes bound GAPDH.
This finding contrasts with PTB ( Fig. 3 b) , which has been described previously to bind to HCV 3hNCR and, more specifically, to loops SL2 and SL3 of the conserved 3hNCR3 (Ito & Lai, 1997 ; Chung & Kaplan, 1999) . Using polyclonal rabbit PTB antibody (R. J. Jackson and S. L. Hunt) and antirabbit-HRP (Sigma), PTB binding to complete 3hNCR1j2j3 and 3hNCR2j3 (Fig. 3 b, lanes 9 and 7) but not to r(U) #& or 3hNCR2 (Fig. 3 b, lanes 3 and 4) was found. PTB did not seem to bind a full-length HCV RNA transcript (Fig. 3 b, lane 10) , but at the same time we failed to detect binding to the conserved 3hNCR3. However, the quantities of PTB captured from liver explant extracts were generally far smaller compared to GAPDH (Fig. 3 a ; also, the exposure times needed for chemiluminescent detection of GAPDH and PTB on identical immunoblots shown in Fig. 3 b and c differed considerably) , perhaps due to the fact that extracts were cytosolic and PTB concentrations in extracts from cell lines and liver explants may differ.
The binding of PTB and another protein (p35) to the HCV 3hNCR was described in detail recently. The binding pattern of p35 described by Luo (1999) was similar to that for GAPDH described herein, but p35 was not characterized further. Gontarek et al. (1999) identified the 3hNCR-binding p35 protein detected by UV-cross-linking from HepG2 extracts as heterogeneous nuclear ribonucleoprotein C (hnRNP C). This is slightly surprising as hnRNP C (C1\C2) has a molecular mass of 41-43 kDa (Dreyfuss et al., 1993 ; Sella et al., 1999) and is one of few hnRNPs which are confined to the nucleus (Dreyfuss et al., 1993) . In our cytosolic liver explant extracts the nuclei were removed and we should not have detected hnRNP C even if it had affinity to HCV 3hNCR. Similarly, the procedure used by Gontarek et al. (1999) should have provided a postnuclear supernatant. Nevertheless, in some capture experiments we observed another protein of similar size obscured partly by GAPDH. As GAPDH has a molecular mass of 36 kDa, there may be another binding protein with a molecular mass of approximately 35 kDa.
In this paper we utilized human liver explant extracts to capture proteins, which is a more authentic system than using extracts from uninfected cell lines and, in the absence of a reproducible in vitro HCV replication system, represents an opportunity to compare HCV-positive and control samples. All the captured proteins were of cellular origin, present in both HCV-positive and control samples, but some were expressed at different levels. This finding needs to be confirmed in a larger series of samples and at the RNA level. Streptavidine\biotin-mediated capture on paramagnetic particles has advantages over UV-cross-linking, allowing more rigorous washing procedures and more flexibility in downstream processing.
GAPDH was shown to interact with viral RNAs Schultz et al., 1996) . It is intriguing that there is abundant cellular protein in cytosolic extracts of human liver tissue, which binds tightly to the HCV 3hNCR structure close to, or at, the replicase complex assembly site and that this protein has been shown to possess RNA helix destabilizing activity.
The replicase complex should contain viral proteins, most notably NS5b (RNA-dependent RNA polymerase) and NS3, which has RNA helicase activity. Both of these proteins have also been shown to bind tightly to poly(U) (Kanai et al., 1995 ; Behrens et al., 1996 ; Morgenstern et al., 1997) and the relative order of polynucleotide affinity for NS3 helicase in the latter study [poly(U) poly(A) poly(C) poly(G)] was identical to that demonstrated for GAPDH. However, under the conditions used in this study we were unable to detect captured proteins present exclusively in HCV-positive extracts. It is possible that differences between the concentrations of abundant cellular proteins such as GAPDH or PTB and viral proteins would be extensive.
The physiological relevance of proteins binding to 3hNCR including GAPDH and their effect on minus-strand RNA synthesis need to be assessed in vivo . In the chimpanzee model (Yanagi et al., 1999 ) the importance of the poly(U\UC) together with the conserved region was confirmed using various HCV RNA mutants. Chimpanzees inoculated with RNA mutants lacking either of these regions failed to develop infection. Further, more detailed studies of viral-cellular protein interactions involved in HCV RNA replication may provide a suitable target for therapeutic intervention. 
